PepGen Inc

Research PepGen Inc (PEPG) on Bullrun: market cap USD 123.12M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerPEPG
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 123.12M
• Financial periodFY2025
• Net income-USD 89.66M
• Free cash flow-USD 81.90M

Valuation Snapshot

latest market cap is USD 123.12M.

About PepGen Inc

PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States. The company engages in the development of PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 2 clinical trial for the treatment of myotonic dystrophy type 1; and FREEDOM2-DM1, which is in Phase 2 for the treatment of myotonic dystrophy type 1. It is also involved in FREEDOM-OLE, an open label expansion study.

Frequently asked questions

What is PepGen Inc's market cap?

PepGen Inc's market capitalization is USD 123.12M.

What does PepGen Inc do?

PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States.